Blogs

The global demand for biologics is rapidly expanding, with therapies ranging from vaccines and monoclonal antibodies to cell and gene therapies. Unlike traditional pharmaceuticals, biologics are highly sensitive to environmental factors such as oxygen, moisture, and microbial contamination. This makes packaging integrity a mission-critical component in safeguarding product stability, efficacy, and patient safety. As regulatory agencies tighten guidelines for container closure integrity (CCI), manufacturers are increasingly turning to advanced, deterministic testing technologies. These modern approaches not only ensure compliance but also future-proof biologics packaging by detecting the smallest possible leaks and vulnerabilities before products reach patients.

Why Biologics Require Robust Packaging Integrity?

Biologics are large, complex molecules that demand highly controlled environments. Small leaks or packaging flaws can result in product degradation, loss of potency, or contamination. Since biologics are often temperature-sensitive and administered directly to patients with critical conditions, any compromise in packaging could have severe consequences.

Traditional approaches, such as dye ingress or microbial challenge tests, fall short for biologics. These methods lack the sensitivity to identify microscopic leaks and often produce results that vary depending on human interpretation. More importantly, they may fail to detect defects that are significant at a molecular level. Regulatory authorities, including the FDA and EMA, now recommend deterministic testing methods that provide measurable, reproducible results. For manufacturers, adopting robust testing not only meets compliance requirements but also protects valuable drug products and ensures patients receive effective treatments.

The Role of Deterministic Testing in Future-Proofing Biologics Packaging

Deterministic testing techniques are at the forefront of ensuring biologics packaging integrity. These methods provide reliable, repeatable results by eliminating the subjectivity found in older test methods. Among the most widely adopted technologies are Helium Leak Detection and MicroCurrent HVLD.

• Helium Leak Detection

Helium Leak Detection is one of the most advanced and sensitive methods available for evaluating the integrity of biologics packaging. The technique involves filling the test container—such as a vial, syringe, or cartridge—with helium, an inert tracer gas known for its small molecular size and ability to diffuse quickly. The container is then placed in a vacuum chamber connected to a mass spectrometer that can detect even the tiniest amount of helium escaping through a defect. This process allows leaks to be measured with extreme accuracy, identifying defects that are invisible to traditional testing methods.

Helium leak detection can identify leaks as small as 1 x 10?¹° mbar L/sec, far beyond the capabilities of traditional test methods. The key benefits of helium leak detection include ultra-high sensitivity, and the ability to generate precise, quantitative data. It is ideal for vials, syringes, and other high-value biologics packaging, ensuring sterility and long-term product stability. By incorporating helium leak detection, manufacturers gain a reliable, future-proof method for ensuring biologics remain safe and effective throughout their shelf life.

• MicroCurrent HVLD

MicroCurrent High Voltage Leak Detection (HVLD) is a specialized technique designed to test the integrity of liquid-filled containers such as ampoules, vials, and pre-filled syringes. The method works by applying a controlled, low-voltage electrical signal across the container while it is rotated or positioned between electrodes. If the container has a defect—such as a pinhole, micro-crack, or closure weakness—the electrical path changes, allowing the system to detect the presence and location of the leak. Unlike traditional HVLD methods that use high voltages, MicroCurrent HVLD employs a much lower voltage, making it safer for delicate biologic products that could otherwise be affected.

This technology offers several advantages: it is non-destructive, capable of detecting pinholes and micro-cracks, gentle on delicate drug formulations, and easily scalable for automated inline testing. By protecting biologics without damaging them, MicroCurrent HVLD ensures both product quality and manufacturing efficiency.

As biologics continue to revolutionize healthcare, their packaging must evolve to provide uncompromising protection and sterility assurance. Traditional probabilistic methods are no longer sufficient to meet the sensitivity, and reliability demands of these complex therapies. Deterministic approaches such as Helium Leak Detection and MicroCurrent HVLD are setting new benchmarks for packaging integrity, offering, highly sensitive, and regulatory-compliant solutions. By adopting these advanced technologies, pharmaceutical manufacturers can not only protect high-value biologics but also build resilient quality systems that adapt to future regulatory and market challenges. Ultimately, advanced integrity testing is key to ensuring that patients receive biologics in their safest, most effective form.

In pharmaceutical manufacturing, packaging integrity directly influences how well products maintain sterility and stability throughout their shelf life. Regulatory standards such as USP <1207> outline structured approaches to evaluate container closure systems, encouraging methods that provide measurable and reproducible outcomes. Among the available techniques, helium leak detection is widely recognized for its unmatched sensitivity in identifying even the smallest leaks. For manufacturers, validation of this method is a decisive step to demonstrate that it performs consistently and aligns with expectations under USP <1207>. This process ensures confidence in packaging systems and safeguards patient safety.

Understanding Helium Leak Detection

Helium leak detection is a deterministic Container Closure Integrity Testing method that uses helium as a tracer gas to identify leaks in container closure systems. Since helium is inert, non-toxic, and has a small atomic size, it readily penetrates through the smallest leaks, making it ideal for sensitive leak detection applications.

The method involves placing the test container—typically filled with helium or exposed to a helium atmosphere—into a vacuum chamber. A mass spectrometer then measures any helium escaping from the package. The presence of helium indicates a leak, and the rate of helium flow provides a quantifiable measure of leak size.

One of the primary advantages of helium leak detection is its ability to detect extremely small leaks, often in the range of 1×10?6 mbar L/s or smaller, levels that correlate with microbial ingress risks. This makes the method highly valuable for testing high-risk products such as injectable drugs, biologics, and implantable medical devices where sterility is non-negotiable.

How to Validate Helium Leak Detection for USP <1207> Compliance?

USP <1207> does not simply recommend a method; it calls for a validated approach tailored to the product and its packaging system. Validation ensures the test delivers consistent outcomes that align with defined expectations. The following steps outline how helium leak detection can be validated effectively:

• Define Leak Rate Thresholds: Establish acceptance limits based on Maximum Allowable Leakage Limits (MALL) and product requirements. This threshold should represent the smallest detectable leak that could impact product sterility.
• Prepare Positive Controls: Use positive controls such as calibrated leaks to demonstrate detection ability. These controls provide a verifiable way to assess sensitivity and reliability.
• Confirm Sensitivity and Repeatability: Perform multiple tests to confirm that helium leak detection consistently identifies the smallest leaks at or below the defined thresholds. This step also demonstrates reproducibility across operators and conditions.
• Evaluate Product Influence: Consider how the presence of liquid product within the container may affect detection. In many cases, helium testing is performed on empty containers or with helium-filled samples to ensure reliable correlation between flow rates and leak pathways.
• Conduct Robustness and System Suitability Testing: Assess how the method performs under varied conditions, such as temperature shifts or handling differences. System suitability checks should be performed routinely to confirm equipment function before use.
• Document for Regulatory Alignment: Maintain thorough records of methodology, acceptance criteria, results, and rationale. Regulatory bodies expect clear evidence showing that the validated method meets defined objectives and can consistently achieve the required detection level.

Helium leak detection provides pharmaceutical manufacturers with a highly sensitive, quantifiable approach to verifying package integrity. By following USP <1207> guidelines, companies can establish validation strategies that demonstrate method accuracy, reproducibility, and suitability for their specific products. A well-validated helium leak detection system allows manufacturers to assess packaging with confidence, ensuring sterility is maintained throughout a product’s shelf life. Beyond compliance, this approach supports trust in pharmaceutical quality by showing that even microscopic leaks can be detected and addressed before reaching patients. In a competitive industry, this level of assurance helps safeguard both product performance and patient well-being.

Lyophilized products, or freeze-dried formulations, are widely used in the pharmaceutical industry due to their extended shelf life and stability. These products are highly sensitive to moisture, which makes container closure integrity (CCI) testing a necessary aspect of packaging validation. Detecting micro-leaks that could allow moisture ingress is a significant focus in lyophilized drug packaging. Standard CCI methods may not always align with the characteristics of freeze-dried products, which require tailored testing strategies. By using approaches that align with the packaging system and the physical properties of lyophilized content, manufacturers can better manage packaging performance over the product's shelf life.

Addressing the Unique Challenges of Lyophilized Products

Lyophilized products present several challenges for packaging evaluation. Their sensitivity to moisture means that even very small breaches in the container system can compromise product quality. Since these products are typically packaged in glass vials with rubber stoppers and aluminum seals, attention must be given to sealing conditions, material compatibility, and stopper positioning.

Unlike liquid-filled containers, lyophilized vials may not respond the same way to traditional test conditions. For example, the absence of liquid can reduce the effectiveness of certain probabilistic methods, such as dye ingress or microbial challenge. In addition, the fragile nature of the lyophilized cake requires non-invasive, non-destructive testing methods that preserve the sample’s structural integrity.

Environmental conditions also influence testing results. Factors such as pressure differential, vacuum stability, and residual gas presence need to be considered when designing a test for a lyophilized vial. Because of these variables, deterministic methods that provide measurable and reproducible outcomes are preferred when tailoring a CCI strategy for freeze-dried products.

Customizing Deterministic CCI Testing Approaches

Vacuum Decay Technology

Vacuum Decay is a non-destructive testing method widely applied in evaluating container integrity. For lyophilized products, it offers a clean and reliable approach without damaging the vial or product. By applying a vacuum to a sealed test chamber and monitoring pressure changes, this technology detects micro-leaks across rigid, semi-rigid, and flexible formats. Its high sensitivity makes it suitable for identifying even the smallest defects, supporting both quality assurance and sustainability by minimizing waste from destructive testing. It is well-suited for laboratory use and can be adapted for manual or automated operation.

Helium Leak Detection

Helium Leak Detection offers high sensitivity and precision, making it well-suited for lyophilized vials that require tight moisture control. In this method, helium is introduced into the container system either during or after sealing, and any escaping gas is measured using a mass spectrometer. This allows detection of even the smallest micro-leaks that could allow moisture ingress. Although it requires specialized equipment and setup, the method provides quantifiable leak rates and supports package development, validation, and quality control. Helium Leak Detection is commonly used during packaging qualification or when the barrier properties of a container need close examination.

Vacuum and Pressure Decay - VeriPac Delta

VeriPac Delta systems use advanced vacuum decay technology supported by dual transducer technology to enhance sensitivity and repeatability. It detects leak rates as small as 5 microns, making it suitable for dry product containers like lyophilized vials and powder-filled packages, as well as liquid-filled vials and prefilled syringes. The system uses high-resolution transducers to monitor vacuum or pressure levels in a test chamber. By measuring changes during a short test cycle, it accurately identifies both gross and micro leaks. VeriPac Delta supports manual or semi-automatic operation, making it ideal for offline lab testing and QA/QC process control without damaging the product or packaging.

Lyophilized drug products require tailored CCI testing approaches due to their sensitivity to moisture and unique container characteristics. Deterministic methods such as Vacuum Decay, Helium Leak Detection, and VeriPac Delta provide non-destructive, data-driven solutions that align well with these requirements. These technologies offer the flexibility to detect a range of leak sizes while maintaining sample stability. By customizing test parameters and aligning methods with specific container formats, manufacturers can improve packaging evaluation and support long-term product stability.

Helium leak detection has become a widely adopted method for evaluating the integrity of plastic ophthalmic containers. Packaging defects, even microscopic, can compromise the sterility and stability of ophthalmic products, affecting their overall performance. Traditional testing methods may not always detect fine leaks, making advanced techniques like helium leak detection valuable for ensuring package reliability. This method offers high sensitivity, detecting even the smallest breaches in container seals. By integrating helium leak detection into quality control processes, manufacturers can enhance leak detection accuracy, minimize the risk of compromised packaging, and support consistent product quality in ophthalmic applications.

Why Integrity Matters in Ophthalmic Packaging?

Ophthalmic packaging is designed to protect product quality, maintain sterility, and prevent contamination. Any compromise in the container’s seal or structure can lead to exposure to environmental elements, affecting the stability and effectiveness of the formulation. Even minor leaks may introduce microbial contamination or cause evaporation, altering the intended concentration of the solution. Ensuring a reliable seal helps maintain the product’s intended shelf life and performance.

Various leak detection methods are available to assess packaging integrity, helping manufacturers identify defects before products reach the market. Deterministic testing approaches offer a way to evaluate packaging without affecting the contents, allowing for thorough analysis while minimizing waste. Regulatory guidelines highlight the significance of package integrity in maintaining product reliability. By implementing effective testing strategies, manufacturers can enhance quality assurance, reduce the risk of defects, and deliver ophthalmic products that meet industry expectations.

How Helium Leak Detection Prevents Leaks in Plastic Ophthalmic Containers?

Helium leak detection provides a reliable method for identifying potential leaks in plastic ophthalmic containers before they reach the market. This technique uses helium as a tracer gas due to its small molecular size and inert properties, allowing it to escape through even the smallest openings in packaging materials.

The process generally involves introducing helium into the container and applying a vacuum to establish a pressure difference between the inside and outside of the package. If any leaks are present, helium escapes and is detected using a highly sensitive helium leak detector. The amount of helium detected is measured and expressed as a leak rate, offering valuable information about the package’s seal quality and overall integrity.

Helium leak testing is extensively used across various industries, especially in the pharmaceutical and parenteral product sectors, where preserving sterile barriers supports product safety and effectiveness. This method is also applied in design validation, quality assurance, failure analysis, and the qualification of manufacturing processes.

Plastic ophthalmic containers must maintain a secure seal to prevent contamination, evaporation, or changes in product concentration. Helium leak detection helps manufacturers verify container closure integrity without damaging the product, ensuring that only well-sealed packages are distributed. This method supports quality assurance efforts by detecting leaks early in the production process, reducing waste, and enhancing product reliability. Adopting this method allows manufacturers to meet stringent packaging requirements while maintaining consistent product performance.

Cold and ultra-cold vials, essential for storing temperature-sensitive pharmaceuticals like vaccines and biologics, demand packaging solutions that maintain integrity under extreme conditions. Helium leak testing has emerged as a reliable method to ensure the integrity of these vials, safeguarding their contents against contamination and preserving efficacy. This advanced technique detects microleaks that may compromise container closure systems, even in ultra-cold environments. By meeting stringent industry standards, helium leak testing supports pharmaceutical manufacturers in achieving packaging reliability, regulatory compliance, and product safety, making it a trusted solution for cold chain applications.

The Challenges of Ultra-Cold Vial Testing

Cold and ultra-cold vial testing presents unique challenges due to the extreme conditions required to maintain the integrity of temperature-sensitive pharmaceutical products. These products, such as vaccines, biologics, and cell and gene therapies, often require storage at temperatures as low as -20°C to -80°C or even colder. Ensuring the integrity of the vials and their closures under such conditions is critical to preserving product efficacy and patient safety.

One major challenge is the potential impact of low temperatures on vial materials. Glass vials, commonly used in pharmaceuticals, may become brittle at ultra-cold temperatures, increasing the risk of cracks or fractures. Similarly, rubber stoppers and seals can lose elasticity, compromising the container closure integrity (CCI). These material changes make it essential to perform rigorous testing that can simulate and validate the performance of packaging components under ultra-cold conditions.

Another challenge involves selecting a reliable testing method. Techniques like helium leak detection are often preferred, as they can accurately identify leaks without damaging the sample. However, testing at ultra-cold temperatures requires specialized equipment and expertise to account for thermal effects on test outcomes.

As cold chain pharmaceuticals become more prevalent, overcoming these challenges is vital for maintaining quality and regulatory compliance.

Why Helium Leak Testing is the Preferred Method for Cold Chain Packaging?

Helium leak detection is a highly sensitive method for evaluating the integrity of complex pharmaceutical and parenteral products. This technique involves introducing helium gas into a sealed system and detecting leaks by measuring the concentration of escaping helium. It is widely used for testing pre-filled syringes, cold form blister packs, foil pouches, and other packaging formats. By providing precise measurements of seal integrity between components of primary container closure systems, helium leak detection has become a trusted solution for ensuring pharmaceutical packaging reliability.

The process works by filling the package with helium and subjecting it to a vacuum, where a helium leak detector measures the helium escaping from the package as a leak rate. Beyond leak detection, this technology supports package design, failure analysis, tooling qualification, packaging line setup, validation, and ongoing quality monitoring. Helium leak detection complies with ASTM F2391, a recognized standard in the pharmaceutical industry, ensuring its relevance and reliability for critical applications.

Helium Leak Testing Applications

• Seal integrity monitoring during stability studies.
• Ensure container closure integrity.
• Verify and predict shelf-life seal integrity.
• Useful for developing pharma product packaging systems in the early stage.
• Selecting closure formulation and configuration.
• CCI testing at cold storage temperatures.

Helium leak testing offers a precise method for addressing the unique demands of cold and ultra-cold vial packaging. It provides real-time results and the test cycle itself is very rapid. It effectively identifies even the smallest leaks, ensuring that container closure systems can withstand extreme temperatures without compromising product safety. By utilizing advanced techniques manufacturers can confidently validate the performance of packaging materials and designs. This testing method supports long-term quality assurance by providing reliable data for packaging optimization. As the pharmaceutical industry continues to innovate, helium leak detection remains a dependable approach for maintaining the integrity of temperature-sensitive products in challenging conditions.

Blister packaging has gained widespread popularity as a versatile and efficient method for packaging various products, particularly in industries like pharmaceuticals, nutraceuticals and food. This packaging solution typically involves the creation of a plastic cavity or blister that is custom designed to securely hold and protect the product it contains. The design of the blister can vary significantly, accommodating a wide range of product shapes and sizes, making it a versatile option for manufacturers. It ensures that the product remains visible to consumers, allowing for easy identification and branding, which is especially crucial in retail settings.

To ensure the product's integrity and longevity, blister packaging is typically sealed with materials like aluminum foil or plastic film. This sealing process not only provides a protective barrier against external factors such as moisture, light, and contaminants but also enhances the product's shelf life. In the pharmaceutical industry, blister packaging is widely used to provide precise dosages of medications and to maintain their stability and sterility. In the food industry, it is often employed to preserve the freshness of perishable items and prevent tampering or contamination. Overall, blister packaging offers a combination of product visibility, protection, and convenience, making it an indispensable choice for many manufacturers looking to meet both functional and marketing requirements.

However, the significance of maintaining the integrity of blister packaging cannot be overlooked, as it plays a pivotal role in avoiding contamination, preserving product freshness, and extending shelf life. One highly effective method employed for assessing blister package integrity is helium leak detection, a process that relies on the unique properties of helium as a tracer gas.

Blister Package Integrity Testing using Helium Leak Detection.

Helium leak detection is a Container Closure Integrity Test (CCIT) that is used to identify leaks in blister packages. The test works by introducing helium gas into the blister package and then measuring the amount of helium that escapes. If there is a leak in the package, helium will escape, and the leak detector will produce a signal.

To test a blister package for leaks using (helium leak detection), the package is first placed in a test chamber. The test chamber is then evacuated, and helium gas is introduced into the package. The package is then held under vacuum for a period of time. After the holding time has elapsed, the test chamber is vented, and the leak detector is used to measure the amount of helium that has escaped from the package. If the amount of helium that has escaped from the package is above a certain threshold, the package is considered defective. Defective packages are rejected and not shipped to customers.

Why is Helium used as a Tracer Gas?

• It is the smallest and lightest gas, so it can easily escape through even the smallest leaks.
• It is inert, meaning that it does not react with other substances.
• It is non-toxic and non-flammable.
• It is abundant and relatively inexpensive.

Helium leak detection is a highly sensitive and reliable method for testing the integrity of blister packages. It is widely used in the pharmaceutical industry to ensure that blister packs are leak-proof and protect the contents from moisture, oxygen, and other contaminants.

Combination products are medical devices that combine two or more different types of medical products (e.g., a drug-device combination or a biologic-device combination) into a single entity. These products present unique challenges in terms of design, development, and regulatory approval due to the integration of different technologies and functionalities. Therefore, it is crucial to use appropriate techniques to evaluate combination product’s safety, efficacy, and overall performance.

The FDA's Center for Devices and Radiological Health (CDRH) and the Center for Drug Evaluation and Research (CDER) developed the "Guidance for Industry and FDA Staff - Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology" to help manufacturers evaluate combination products containing nanomaterials. While this guidance specifically addresses nanotechnology, many of the concepts and principles apply more broadly to evaluating combination products.

What are the three main categories of combination products?

Combination products are categorized into three main types based on their primary mode of action.

1.Drug-Device Combination Products: These products combine a drug and a medical device into one single entity. The drug and device components work together to achieve the intended therapeutic effect. An example of this type of combination product is an auto-injector that contains a drug and a delivery device.

2. Biologic-Device Combination Products:These products combine a biological product (such as a vaccine, cellular therapy, or tissue product) with a medical device. The device is integral to the administration or use of the biological product. An example of this type of combination product is a pre-filled syringe containing a biological medication.

3. Drug-Biologic Combination Products: These products combine a drug and a biological product. This category is less common than the others, but it involves combining a drug with a biologically sourced material. An example of this type of combination product is a drug formulated with a growth factor derived from human tissues.

Combination Products Quality Control Techniques

Microcurrent HVLD technology

MicroCurrent High Voltage Leak Detection (HVLD mc) is a non-destructive container closure integrity testing method that has been proven to be significantly more effective in identifying leaks in various types of parenteral and pharmaceutical applications. It may be used to check for leaks in nonporous, rigid, or flexible packaging as well as packaging that contains liquids. Tests for high voltage leak detection are carried out using electrical conductivity and resistance theories. This method operates by transmitting high voltage, low current impulses through sample packages. When there is a leak, the electrical resistance of the sample falls, causing an increase in current. HVLD technology depends on the "flow" of current, compared to conventional leak detection methods that depend on the movement of gas or liquid.

MicroCurrent HVLD Applications

• Vials
• Ampoules
• Cartridges
• Pre-filled Syringes
• BFS

Helium Leak testing

Helium leak detection is a method for finding leaks in a variety of sealed or enclosed systems by utilizing helium as a "tracer" gas. It is a CCI technique used to evaluate the integrity of critical injectable or parenteral products. Since helium is non-toxic, non-flammable, and non-condensable, helium gas is a great option for tracer gas. Helium is present in the atmosphere in amounts of little more than 5 ppm, making minor leaks easy to pass through. Helium is also more readily available and less expensive than other tracer gases, available in a variety of cylinder sizes. The test is performed by attaching the test component to the leak detector, which is then filled with helium gas. Helium escapes from the test components when there is a leak, and this partial pressure is measured, with the results shown on the meter.

Benefits of Helium Leak Testing

• Practical and sensitive flow-based leak test method,
• Enables the discovery of extremely small microleaks.
• Detects leaks with sensitivity level as low as 1x10-10 mbar L/sec.
• Helium is a non-explosive, non-toxic and non-destructive tracer gas.
• Applicable across package design, failure analysis, packaging line setup and validation.
• A faster test cycle reduces cost and total processing time.

The specific techniques and requirements for evaluating combination products may vary depending on the nature of the product (e.g., drug-device vs. biologic-device) and the intended use. Manufacturers are encouraged to engage in early communication with regulatory authorities to clarify the requirements and expectations for their combination product. Additionally, seeking the expertise of professionals with experience in evaluating combination products can be beneficial throughout the development and approval processes.

The quality of the product and the maintenance of the sterile barrier against outside forces are both critically dependent on the packaging. Even a tiny hole in the packaging might allow moisture, reactive gases, or other dangerous elements to enter the product, limiting its ability to heal. Additionally, a contaminated pharmaceutical product can cause serious health issues to the user, making it more of a threat than a treatment. Maintaining Container Closure Integrity is extremely important due to the sensitive nature of pharmaceutical products.

Container Closure Integrity testing is a leak detection technique for determining how well sterile barriers are maintained against external contamination. These tests may be roughly divided into probabilistic and deterministic test methods. Manufacturers choose deterministic test procedures since they provide precise, guaranteed quantitative results. One such test method is helium leak detection technology.

Helium Leak Detection Technology Overview

Helium leak testing is the method of identifying leaks in various enclosed or sealed systems by utilizing helium as a "tracer" gas and measuring the concentration of the gas as it leaves due result of a leak. A vial is a good example of package system. A pre-filled syringe, a foil pouch, and a cold form blister card are some other examples. Each of these package types is intended to keep the pharmaceutical product contained while preventing the entry of potentially dangerous environmental contaminants like dust, bacteria, or even gases. Helium leak testing method can evaluate these package types. It is a highly efficient approach for finding leaks that provide quantitative leak rate data considerably beyond the capabilities of existing leak testing techniques.

The following describes how helium leak detection works: The package is initially vacuumed and helium-filled. The amount of helium escaping the package is then measured quantitatively and expressed as a leak rate using a helium leak detector. The technique is also ideally suited for packaging line setup and validation, failure analysis, tool qualification, monitoring product quality, and package design.

Why Use Helium as a Tracer Gas?

• Deterministic seal quality inspection method that produces quantitative outcomes.
• Regardless of color, transparency, print, surface polish, or porosity, this method works for all material types and combinations.
• Non-destructive and non-subjective test technique that does not require any sample preparation.
• Technology may be used for 100% online final pouch seal defect detection.
• Seal quality inspection results are repeatable, reproducible and reliable.
• Cost-effective solution for testing seal integrity and seal analysis that characterizes the overall quality and uniformity of the seal.

Helium Leak Detection Merits

• Practical and sensitive flow-based leak test method.
• Enables the discovery of extremely small microleaks.
• Detects leaks with sensitivity levels as low as 1x10-10 mbar L/sec.
• Helium is a non-explosive, non-toxic and non-destructive tracer gas.
• Applicable across package design, failure analysis, packaging line setup and validation.
• Faster test cycle reduces cost and total processing time.

Applications of Helium Leak Detection

• Vials
• Pre-filled syringes
• Blister packs
• Combination products
• Bottles
• Foil pouches

Helium leak detection is the best option for evaluating the inherent integrity of specific primary container closure systems of pharmaceutical and parenteral products. It is a commonly used technology in early stage pharmaceutical package development and component compatibility evaluation. In comparison to other leak test techniques, helium leak testing has the highest level of sensitivity, making it the most used CCI test method. In accordance with ASTM F2391, helium leak detection is a widely used method in the pharmaceutical industry.